Immunohistochemical expression of p16 and herpes simplex virus type 2 in squamous intraepithelial lesions and cervical cancer;A expressão da proteína p16 e herpes simples vírus tipo 2 em lesões pré-neoplásicas e neoplásicas do colo do útero

Revista Brasileira de Ginecologia e Obstetricia

Volumn 30, Issue 2, 2008, Pages 61-66

  Salcedo, Mila De Moura Behar Pontremoli ^a,b   Da Silviera, Gustavo Py Gomes ^a   Zettler, Cláudio Galeano ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b Fundacao Universidade Federal de Ciencias da Saude de Porto Alegre UFCSPA ^*  (Brazil)

Author keywords

Cervical intraepithelial neoplasia; Genes, p16; Herpesvirus 2, human; Immunohistochemistry; Precancerous conditions; Uterine cervical neoplasm

Indexed keywords

P16 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CHEMISTRY; CROSS-SECTIONAL STUDY; FEMALE; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; MIDDLE AGED; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; FEMALE; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM PROTEINS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 45749105123     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-72032008000200003     Document Type: Article

References (27)

1. Ministério da Saúde. Instituto Nacional de Câncer (INCA). Estimativa 2006: incidência de câncer no Brasil [ Internet]. Rio de Janeiro: INCA; 2005 [citado 2007 Abr 7]. Disponível em: http://www.inca.gov.br/estimativa/2006.
2. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342-50.
3. Ma L, Fisk JM, Zhang RR, Ulukus EC, Crum CP, Zheng W. Eosinophilic dysplasia of the cervix: a newly recognized variant of cervical squamous intraepithelial neoplasia. Am J Surg Pathol. 2004;28(11):1474-84.
4. McCluggage WG. Immunohistochemistry as a diagnostic aid in cervical pathology. Pathology. 2007;39(1):97-111.
5. Cox JT, Schiffman M, Solomon D; ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. 2003;188(6):1406-12.
6. Cotran RS, Kumar V, Collins T. Neoplasia. In: Cotran RS, Kumar V, Collins T, editors. Robbins pathologic basis of disease. 6th ed. Philadelphia: WB Saunders; 1999. p. 260-327.
7. Vecchione A, Cermele C, Giovagnoli MR, Valli C, Alimandi M, Carico E, et al. p53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix. Gynecol Oncol. 1994;55(3 Pt 1):343-8.
8. Golijow CD, Abba MC, Mourón SA, Laguens RM, Dulout FN, Smith JS. Chlamydia trachomatis and human papillomavirus infections in cervical disease in Argentine women. Gynecol Oncol. 2005;96(1):181-6.
9. Kruse AJ, Skaland I, Janssen EA, Buhr-Wildhagen S, Klos J, Arends MJ, et al. Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability. Int J Gynecol Pathol. 2004;23(2):100-9.
10. Rivoire WA, Capp E, Corleta HE, Silva ISB. Bases biomoleculares da oncogênese cervical. Rev Bras Cancerol. 2001;47(2):179-84.
11. O'Neill CJ, McCluggage WG. p 16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol. 2006;13(1):8-15.
12. Santos M, Montagut C, Mellado B, García A, Ramón y Cajal S, Cardesa A, et al. Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol. 2004;23(3):206-14.
13. Nogueira MC, Guedes Neto Ede P, Rosa MW, Zettler E, Zettler CG. Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva. Pathol Oncol Res. 2006;12(3):153-7.
14. Focchi GR, Silva ID, Nogueira-de-Souza NC, Dobo C, Oshima CT, Stavale JN. Immunohistochemical expression of p16(INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions. J Low Genit Tract Dis. 2007;11(2):98-104.
15. Eleutério J Jr, Giraldo PC, Gonçalves AK, Cavalcante DI, de Almeida Ferreira FV, Mesquita SM, et al. Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus. Acta Obstet Gynecol Scand. 2007;86(1):94-8.
16. Azumi N, Czernobilsky B. Immunohistochemistry. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. 5th ed. Baltimore: Springer; 2002. p. 1251-76.
17. Lanham S, Herbert A, Basarab A, Watt P. Detection of cervical infections in colposcopy clinic patients. J Clin Microbiol. 2001;39(8):2946-50.
18. Branton PA. Protocol revision date: January 2005. Washington, D.C.: College of American Pathologists (CAP); 2005. [Based on WHO, AJCC/UICC, TNM 6th and FIGO Annual Report].
19. Hunt CR, Hale RJ, Buckley CH, Hunt J. p 53 expression in carcinoma of the cervix. J Clin Pathol. 1996;49(12):971-4.
20. Chan PK, Chan MY, Li WW, Chan DP, Cheung JL, Cheng AF. Association of human beta-herpesviruses with the development of cervical cancer: bystanders or cofactors. J Clin Pathol. 2001;54(1):48-53.
21. International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer. 2006;118(6):1481-95.
22. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244-65.
23. Pecorelli S, editor. FIGO Annual Report on the results of treatment in gynecological cancer. J Epidemiol Biostat. 2001;6:1-184.
24. Crum CP. The female and genital tract. In: Cotran RS, Kumar V, Collins T, editor. Robbins pathologic basis of disease. 6th ed. Philadelphia: WB Saunders; 1999. p. 329-402.
25. Lehtinen M, Koskela P, Jellum E, Bloigu A, Anttila T, Hallmans G, et al. Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the Nordic countries. Am J Epidemiol. 2002;156(8):687-92.
26. Pérez LO, Barbisan G, Abba MC, Laguens RM, Dulout FN, Golijow CD. Herpes simplex virus and human papillomavirus infection in cervical disease in Argentine women. Int J Gynecol Pathol. 2006;25(1):42-7.
27. Zettler CG. Detecção imuno-histoquímica do p53 no carcinoma epidermóide do colo do útero e sua associaç ão com o papiloma viral humano e vírus herpes simples tipo 2 [tese]. Porto Alegre: Fundação Faculdade Federal de Ciências Médicas; 1996.